Capitalmind Flexi Cap Fund
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity & equity related instruments across market capitalization i.e. large-cap, mid-cap and small-cap stocks.
Growthvine rating: 1/5 — ranked #51 of 52 in category.
Fund basics
| Category | Equity: Flexi Cap |
|---|
| NAV | ₹10.27 (as of 2026-08-21) |
|---|
| AUM | ₹452 Cr |
|---|
| Expense ratio | 2.08% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Anoop Vijaykumar |
|---|
| Exit load | 1% for redemption within 1 month |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | -9.33% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 61.9% of Nifty 500's upside and 64.3% of its downside.
Market cap allocation
| Large cap | 26.4% |
|---|
| Mid cap | 40.6% |
|---|
| Small cap | 33.0% |
|---|
Concentration
| Top 5 holdings | 19.8% |
|---|
| Top 10 holdings | 37.5% |
|---|
| Total holdings | 32 |
|---|
| Index overlap | 8.7% |
|---|
| Active share | 91.3% |
|---|
Top holdings
- Federal Bank Ltd. — 4.2%
- Cummins India Ltd. — 4.0%
- Welspun Corp Limited — 3.9%
- Bank of maharashtra — 3.9%
- Torrent Pharmaceuticals Ltd. — 3.8%
- R R KABEL LIMITED — 3.7%
- Laurus Labs Limited — 3.6%
- Karur Vysya Bank Ltd. — 3.6%
- Hindalco Industries Ltd. — 3.5%
- Bharat Forge Ltd — 3.4%
Top sectors
- Pharma & Biotech — 21.9%
- Banking & Financial — 21.8%
- Industrial Products — 16.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.5% | Q3 | #28 of 50 |